Clinical Trials
11 trialsNCT04902833 2026-05-19
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Massachusetts General Hospital
Completed
NCT07249476 2026-04-29
ENKLA-M
Nantes University Hospital
Not yet recruiting
NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
NCT06510868 2026-03-05
MDS & PRRT
University Health Network, Toronto
Recruiting
NCT01728402 2026-02-17
Pathogenesis of Hematologic Malignancies
OHSU Knight Cancer Institute
Enrolling by invitation
NCT03842696 2026-01-27
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
University of Michigan Rogel Cancer Center
Phase 1/2 Active not recruiting
NCT05983991 2025-12-26
GATA-2
Institut Claudius Regaud
Phase NA Recruiting
NCT05735704 2025-03-26
SANGUINE
JaxBio Ltd
Unknown
NCT01904136 2024-01-24
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01471067 2017-04-28
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02489929 2015-07-03
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
Phase NA Unknown